Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response
Identifieur interne : 001D04 ( Main/Exploration ); précédent : 001D03; suivant : 001D05Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response
Auteurs : Takashi Tomoda [États-Unis] ; Hideo Morita [États-Unis] ; Takanobu Kurashige [États-Unis] ; Hunein F. Maassab [États-Unis]Source :
- Vaccine [ 0264-410X ] ; 1995.
English descriptors
- Teeft :
- Antibody, Antibody response, Cultured lymphocytes, Examinee, Healthy adults, Hlnl, Hlnl virus, Immunological factors, Important role, Important roles, Influenza, Influenza cytotoxic, Influenza epidemics, Influenza infection, Influenza vaccine, Influenza virus, Influenza virus vaccine, Intranasal administration, Kochi, Kochi prefecture, Lower morbidity rate, Lymphocyte, Lymphocyte activation, Lymphocyte proliferation, Lymphocyte proliferation assay, Nasal, Nasal wash specimen, Nasal wash specimens, Questionnaire survey, Saliva samples, Second vaccination, Significant change, Significant increase, Stimulation index, Untreated groups, Untreated ones, Vaccinated, Vaccinated examinees, Vaccinated individuals, Vaccinated students, Vaccination, Vaccine, Virus, Virus infection.
Abstract
Abstract: To clarify which immunological factors were more effective in preventing influenza virus infection, we measured immunological parameters induced by vaccination and infection in vivo and in vitro. Healthy adult subjects (n = 128) were divided into vaccinated (n = 85) and untreated (n = 43) groups. Eighty-five were vaccinated intranasally with a trivalent cold-adapted recombinant influenza virus vaccine containing type A (H1N1 and H3N2) and B viruses. Subjects were mostly seropositive before vaccination. In 29 (80.6%) of the 36 examinees showing a prevaccination HI antibody titre of less than 1:128, the titre increased more than four times after vaccination. On the other hand, an increase of more than four times was found in four (8.2%) of the 49 individuals who had shown a prevaccination titre of more than 1:128. The IgA antibody was negligibly detected in the nasal wash specimens before vaccination, and was induced by vaccination in some cases. Lymphocyte proliferation and interleukin 2 (IL-2) production in cultured lymphocytes of the same subjects stimulated by H1N1 virus in vitro were correlated with the HI antibody titre. However, the interferon γ (IFN-γ) production was low before vaccination, regardless of the HI antibody titre, and showed a significant increase after vaccination. It was suggested that local IgA response and IFN-γ production play important roles in the prevention of influenza. Since there was the outbreak of influenza A (H1N1) in Kochi Prefecture after completion of blood samples 6–8 weeks after the second vaccination, we examined the above hypothesis. A significantly (p<0.01) lower morbidity rate in the vaccinated examinees was found. The HI antibody, lymphocyte DNA synthesis and IL-2 production, which had been increased by vaccination, showed little further increase in response to the epidemic. In contrast, local IgA response and IFN-γ production, which had been increased by vaccination, showed another increase because of the epidemc.
Url:
DOI: 10.1016/0264-410X(95)93134-U
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C15
- to stream Istex, to step Curation: 000C15
- to stream Istex, to step Checkpoint: 000A79
- to stream Main, to step Merge: 001D78
- to stream Main, to step Curation: 001D04
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response</title>
<author><name sortKey="Tomoda, Takashi" sort="Tomoda, Takashi" uniqKey="Tomoda T" first="Takashi" last="Tomoda">Takashi Tomoda</name>
</author>
<author><name sortKey="Morita, Hideo" sort="Morita, Hideo" uniqKey="Morita H" first="Hideo" last="Morita">Hideo Morita</name>
</author>
<author><name sortKey="Kurashige, Takanobu" sort="Kurashige, Takanobu" uniqKey="Kurashige T" first="Takanobu" last="Kurashige">Takanobu Kurashige</name>
</author>
<author><name sortKey="Maassab, Hunein F" sort="Maassab, Hunein F" uniqKey="Maassab H" first="Hunein F." last="Maassab">Hunein F. Maassab</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A29E5FF5D88DFDA97C91FC301EC44CFA1A60B16E</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1016/0264-410X(95)93134-U</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-X7L6SPWB-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C15</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000C15</idno>
<idno type="wicri:Area/Istex/Curation">000C15</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A79</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A79</idno>
<idno type="wicri:doubleKey">0264-410X:1995:Tomoda T:prevention:of:influenza</idno>
<idno type="wicri:Area/Main/Merge">001D78</idno>
<idno type="wicri:Area/Main/Curation">001D04</idno>
<idno type="wicri:Area/Main/Exploration">001D04</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response</title>
<author><name sortKey="Tomoda, Takashi" sort="Tomoda, Takashi" uniqKey="Tomoda T" first="Takashi" last="Tomoda">Takashi Tomoda</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Morita, Hideo" sort="Morita, Hideo" uniqKey="Morita H" first="Hideo" last="Morita">Hideo Morita</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kurashige, Takanobu" sort="Kurashige, Takanobu" uniqKey="Kurashige T" first="Takanobu" last="Kurashige">Takanobu Kurashige</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maassab, Hunein F" sort="Maassab, Hunein F" uniqKey="Maassab H" first="Hunein F." last="Maassab">Hunein F. Maassab</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, Kochi Medical School, Okoh-cho Nankoku, Kochi, 783 Japan and Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1995">1995</date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="185">185</biblScope>
<biblScope unit="page" to="190">190</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antibody</term>
<term>Antibody response</term>
<term>Cultured lymphocytes</term>
<term>Examinee</term>
<term>Healthy adults</term>
<term>Hlnl</term>
<term>Hlnl virus</term>
<term>Immunological factors</term>
<term>Important role</term>
<term>Important roles</term>
<term>Influenza</term>
<term>Influenza cytotoxic</term>
<term>Influenza epidemics</term>
<term>Influenza infection</term>
<term>Influenza vaccine</term>
<term>Influenza virus</term>
<term>Influenza virus vaccine</term>
<term>Intranasal administration</term>
<term>Kochi</term>
<term>Kochi prefecture</term>
<term>Lower morbidity rate</term>
<term>Lymphocyte</term>
<term>Lymphocyte activation</term>
<term>Lymphocyte proliferation</term>
<term>Lymphocyte proliferation assay</term>
<term>Nasal</term>
<term>Nasal wash specimen</term>
<term>Nasal wash specimens</term>
<term>Questionnaire survey</term>
<term>Saliva samples</term>
<term>Second vaccination</term>
<term>Significant change</term>
<term>Significant increase</term>
<term>Stimulation index</term>
<term>Untreated groups</term>
<term>Untreated ones</term>
<term>Vaccinated</term>
<term>Vaccinated examinees</term>
<term>Vaccinated individuals</term>
<term>Vaccinated students</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Virus</term>
<term>Virus infection</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: To clarify which immunological factors were more effective in preventing influenza virus infection, we measured immunological parameters induced by vaccination and infection in vivo and in vitro. Healthy adult subjects (n = 128) were divided into vaccinated (n = 85) and untreated (n = 43) groups. Eighty-five were vaccinated intranasally with a trivalent cold-adapted recombinant influenza virus vaccine containing type A (H1N1 and H3N2) and B viruses. Subjects were mostly seropositive before vaccination. In 29 (80.6%) of the 36 examinees showing a prevaccination HI antibody titre of less than 1:128, the titre increased more than four times after vaccination. On the other hand, an increase of more than four times was found in four (8.2%) of the 49 individuals who had shown a prevaccination titre of more than 1:128. The IgA antibody was negligibly detected in the nasal wash specimens before vaccination, and was induced by vaccination in some cases. Lymphocyte proliferation and interleukin 2 (IL-2) production in cultured lymphocytes of the same subjects stimulated by H1N1 virus in vitro were correlated with the HI antibody titre. However, the interferon γ (IFN-γ) production was low before vaccination, regardless of the HI antibody titre, and showed a significant increase after vaccination. It was suggested that local IgA response and IFN-γ production play important roles in the prevention of influenza. Since there was the outbreak of influenza A (H1N1) in Kochi Prefecture after completion of blood samples 6–8 weeks after the second vaccination, we examined the above hypothesis. A significantly (p<0.01) lower morbidity rate in the vaccinated examinees was found. The HI antibody, lymphocyte DNA synthesis and IL-2 production, which had been increased by vaccination, showed little further increase in response to the epidemic. In contrast, local IgA response and IFN-γ production, which had been increased by vaccination, showed another increase because of the epidemc.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Michigan</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Michigan"><name sortKey="Tomoda, Takashi" sort="Tomoda, Takashi" uniqKey="Tomoda T" first="Takashi" last="Tomoda">Takashi Tomoda</name>
</region>
<name sortKey="Kurashige, Takanobu" sort="Kurashige, Takanobu" uniqKey="Kurashige T" first="Takanobu" last="Kurashige">Takanobu Kurashige</name>
<name sortKey="Maassab, Hunein F" sort="Maassab, Hunein F" uniqKey="Maassab H" first="Hunein F." last="Maassab">Hunein F. Maassab</name>
<name sortKey="Morita, Hideo" sort="Morita, Hideo" uniqKey="Morita H" first="Hideo" last="Morita">Hideo Morita</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:A29E5FF5D88DFDA97C91FC301EC44CFA1A60B16E |texte= Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response }}
This area was generated with Dilib version V0.6.33. |